Semin Reprod Med 2007; 25(3): 135-136
DOI: 10.1055/s-2007-973425

Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Thomas M. Price, M.D.

Bruce R. Carr1  Editor in Chief 
  • 1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
Further Information

Publication History

Publication Date:
20 April 2007 (online)

The non-genomic actions of steroidal hormones have gained significant attention by investigators in recent years. As the readers of Seminars in Reproductive Medicine know, I have often asked one of my former fellows to serve as Guest Editor for Seminars in Reproductive Medicine. I am fortunate to have trained fellows with a wide variety of research and clinical interests. In this issue, Dr. Thomas Price, who came to University of Texas Southwestern in 1989 for a 2-year fellowship, has had a successful career studying the non-genomic actions of progesterone.

Dr. Price currently is Associate Professor and Director of the fellowship training program in the Division of Reproductive Endocrinology and Fertility of Duke University, Durham, NC. He is involved in all aspects of academic medicine, including patient care, medical education, and clinical and basic science research. He has run his own basic science research laboratory since completing his fellowship in 1991. His research interests have always focused on sex steroid receptors; the most recent field of study is non-genomic actions of progesterone.

Dr. Price received his undergraduate degree in Chemistry, Medical Degree with Honors, and residency training in obstetrics and Gynecology from the University of North Carolina at Chapel Hill. In 1989, he left North Carolina to complete his reproductive endocrinology fellowship at the University of Texas Southwestern Medical Center. After fellowship, Dr. Price joined the Division of Reproductive Endocrinology at the Greenville Hospital System, with joint appointments at the University of South Carolina and the Medical University of South Carolina. In Greenville, Dr. Price helped develop one of the most successful in vitro fertilization (IVF) programs in the Southeast, established a clinical research program for the department, and continued his basic research through a cooperative agreement with Clemson University. In 2003, he relocated to his present position at Duke University.

Dr. Price is a member of Phi Beta Kappa and Alpha Omega Alpha Medical Honor Society. His previous awards include the Charles A. Hunter Prize Thesis Award from The American Gynecological and Obstetrical Society, the American Health Assistance Foundation Ruth Salta Junior Investigator Achievement Award, the Association of Professors of Gynecology and Obstetrics Medical Student Teaching Award, and two Society of Gynecological Investigation Wyeth Presidential Awards. Previous funding sources include the American Health Assistance Foundation, the Department of Defense, the Pardee Foundation, the Endocrine Society, the Society of Gynecological Investigation, the American Heart Association, and the National Institutes of Health (NIH). He current holds a NIH/National Institute of Child Health and Human Development grant to study a novel non-genomic progesterone receptor. Dr. Price is well published, with more than 110 articles and abstracts, and has been recognized for six plenary or prize presentations.

Dr. Price is board certified in Obstetrics and Gynecology and Reproductive Endocrinology. He has served as a reviewer for multiple journals, including Journal of Clinical Endocrinology and Metabolism, Biotechniques, Molecular and Cellular Endocrinology, Journal of the Society of Gynecological Investigation, Obstetric & Gynecology, Fertility and Sterility, and American Journal of Obstetrics and Gynecology. Dr. Price has mentored 16 students in basic science research, including undergraduates, medical students, residents, fellows, and graduate students, with students graduating at both the Master's and Ph.D. levels.

For this issue of Seminars in Reproductive Medicine, Dr. Price has recruited some of the world's experts on investigations of nontraditional actions of sex steroids. The articles focus on actions of sex steroids independent of the classical control of nuclear transcription, with emphasis on systems including the brain, vasculature, breast, and reproductive tissues of the ovary and testes.